Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 153 results for "vldl"

Patient-Level Discordance in Population Percentiles of the TC/...

1 * ; Renato Quispe 2 ; Erin D. Michos 3 ; Allan D. Sniderman 4 ; Peter P. Toth 5 ; Maciej Banach 6 ; Krishnaji R. Kulkarni 7 ; Josef Coresh 8 ; Roger S. Blumenthal 2 ; Steven R. Jones 2 ; Seth S. Martin 3 1 Johns Hopkins Ciccarone ... Circulation: Cardiovascular Interventions, 1 day ago

3 images for "vldl"

Indian Express, 1 week ago
MDLinx, 1 month ago
Boca Raton Magazine, 4 months ago
NDTV

Yoga practitioners at less risk of inflammatory diseases:study

New Delhi: Yoga practitioners are at lesser risk of developing inflammation that could lead to cardiovascular diseases, cancer and Alzheimer, a study by Indian Institute of Science (IIS) has revealed. Inflammation is body's response to an injury and ...
 ZeeNews.com2 days ago From the lab: Effect of yoga on body's ability to fight back  Indian Express6 days ago Yoga Can Help Keep Heart Disease, Cancer, Dementia Away, Says Study  New Indian Express1 week ago
[x]  

Stevia First: Reinventing Nutrition by Replacing Sugar

2015-07-01 URL: Metabolic syndrome is a combination of factors that multiply a person's risk for heart disease, diabetes, and stroke that affects roughly 34% of American adults. The condition is characterized by raised triglycerides, reduced HDL ...
 Food & Beverage Asia3 days ago STEVIA FIRST CORP : Stevia First: Reinventing Nutrition by Replacing Sugar  4 Traders2 weeks ago
[x]  
Indian Express

Diet diary: Dairy may not be as bad as you thought

The milk-based products have become a subject of controversy for various reasons. Among the first casualties of a calorie or cholesterol free diet are dairy products. But should those starting these diets sacrifice milk-based products? The jury on ...
 Indian Express1 week ago

Potent peroxisome proliferator-activated receptor-{alpha} agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome

Abstract Aims Fibrate medications weakly stimulate the nuclear receptor peroxisome proliferator-activated receptor-α (PPAR-α) and are currently employed clinically in patients with dyslipidaemia. The potent and selective agonist of PPAR-α ...
 European Heart Journal1 week ago

VIDEO: Genetic variants offer insight into effects of lifelong elevation, decrease in lipids

CHICAGO — Kevin C. Maki, PhD, CLS, discusses the influence of genetic variants on lipoprotein lipid levels and CVD risk. Maki, chief science officer at Midwest Center for Metabolic and Cardiovascular Research, gave a presentation on the topic ...
 Orthopedics Today2 weeks ago

Fusobacterium nucleatum Alters Atherosclerosis Risk Factors and Enhances Inflammatory Markers with an Atheroprotective Immune Response in ApoEnull Mice

by Irina M. Velsko, Sasanka S. Chukkapalli, Mercedes. F. Rivera-Kweh, Hao Chen, Donghang Zheng, Indraneel Bhattacharyya, Pandu R. Gangula, Alexandra R. Lucas, Lakshmyya Kesavalu The American Heart Association supports an association between ...
 Plosone.org2 weeks ago

Methods for treating steatotic disease

Methods for treating fatty liver disease, e.g., hepatic steatosis, using peptide fragments of the C-terminal end of glucagon-like peptide-1 (GLP-1), e.g., GLP-1(28-36). Description of the Invention TECHNICAL FIELD This invention relates to ...
 PharmCast2 weeks ago
Seeking Alpha

Matinas Biopharma Holdings, Inc. (MTNB: OTCQB) | Matinas BioPharma's MAT9001 Demonstrates Superiority in Reducing Triglycerides, Lipids, Apolipoproteins and PCSK9 Levels in Head-to-Head Study With Vascepa(R)

(GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company, announced the presentation of data from a head-to-head study that showed MAT9001 , a prescription-only omega-3 fatty acid-based ...
 OTC Markets2 weeks ago Matinas BioPharma's MAT9001 Demonstrates Superiority in Reducing Triglycerides, Lipids, Apolipoproteins and PCSK9 Levels in Head-to-Head Study With Vascepa(R)  Securities Technology Monitor2 weeks ago MATINAS BIOPHARMA : MAT9001 Demonstrates Superiority in Reducing Triglycerides, Lipids, Apolipoproteins and PCSK9 Levels in Head-to-Head Study With...  4 Traders2 weeks ago Matinas MAT9001 Beats Vascepa In Head-To-Head Trial  Seeking Alpha1 month ago
[x]  

Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes

Natural history and pathophysiology of type 2 diabetes Type 2 diabetes (T2DM) is a systemic disease characterized by multiple pathophysiologic disturbances. 1 Individuals destined to develop T2DM manifest moderatesevere insulin resistance in muscle ...
 European Heart Journal3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less